{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:32:31Z","timestamp":1785717151265,"version":"3.56.0"},"reference-count":50,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To assess vaccination coverage and predictors of vaccination among a Canadian population of rheumatology patients in routine clinical care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>In this cross-sectional study, consecutive adult patients presenting to a tertiary rheumatology clinic at the McGill University Health Center between May and September 2015 were asked to fill a survey on vaccination. Patients self-identified as having rheumatoid arthritis (RA), systemic autoimmune rheumatic diseases (SARD), spondyloarthropathies (SpA), or other diseases (OD). Multivariate logistical regression analyses were performed to evaluate patient and physician factors associated with various vaccinations [for influenza, pneumococcus, and hepatitis B virus (HBV)]. Published Quebec general population influenza and pneumococcal vaccination rates in those aged \u2265 65 years were used as comparative baseline rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Three hundred fifty-two patients were included in the analysis (RA: 136, SARD: 113, SpA: 47, OD: 56). Vaccination rates were reported as follows: (1) influenza: RA 48.5%, SARD 42.0%, SpA 31.9%, OD 88.9%, Quebec general population 58.5%; (2) pneumococcal: RA 42.0%, SARD 37.8%, SpA 29.7%, OD 33.3%, Quebec general population 53.2%; (3) HBV: RA 33.6%, SARD 55.6%, SpA 73.5%, OD 36.8%; and (4) herpes zoster: RA 5.6%, SARD 28.6%, SpA 25.0%, OD 16.7%. Physician recommendation was the strongest independent predictor of vaccination across all vaccine types (influenza: OR 8.56, 95% CI 2.80\u201326.2, p &lt; 0.001; pneumococcal: OR 314, 95% CI 73.0\u20131353, p &lt; 0.001; HBV: OR 12.8, 95% CI 5.27\u201331.1, p &lt; 0.001). Disease group, disease duration, comorbidities, treatment type, and being followed by a primary care physician were not significantly associated with vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>There is suboptimal immunization coverage among ambulatory rheumatology patients. An important role for patient and physician education is highlighted in our study, especially because physician recommendation of vaccination was strongly predictive of vaccine uptake.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.181376","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:19:53Z","timestamp":1563207593000},"page":"770-778","source":"Crossref","is-referenced-by-count":43,"title":["Suboptimal Immunization Coverage among Canadian Rheumatology Patients in Routine Clinical Care"],"prefix":"10.3899","volume":"47","author":[{"given":"Tedi","family":"Qendro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1852-6495","authenticated-orcid":false,"given":"Mar\u00eda Laura","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Panopalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3251-958X","authenticated-orcid":false,"given":"Brian J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-8334","authenticated-orcid":false,"given":"In\u00e9s","family":"Colmegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6718-2468","authenticated-orcid":false,"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"2020050109252807000_47.5.770.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.12.003"},{"key":"2020050109252807000_47.5.770.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq183"},{"key":"2020050109252807000_47.5.770.3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrrheum.2014.206","article-title":"Vaccination of patients with autoimmune inflammatory rheumatic diseases","volume":"11","author":"Westra","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2020050109252807000_47.5.770.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.05.003"},{"key":"2020050109252807000_47.5.770.5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-13-158"},{"key":"2020050109252807000_47.5.770.6","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2011-200168"},{"key":"2020050109252807000_47.5.770.7","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"2020050109252807000_47.5.770.8","unstructured":"Government of Canada . Update on the use of herpes zoster vaccine: an Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). [Internet. Accessed October 21, 2019.] Available from: www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/update-use-herpes-zoster-vaccine.html"},{"key":"2020050109252807000_47.5.770.9","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/ibd\/izy150","article-title":"Herpes zoster in patients receiving JAK inhibitors for ulcerative colitis: mechanism, epidemiology, management, and prevention","volume":"24","author":"Colombel","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2020050109252807000_47.5.770.10","unstructured":"Comit\u00e9 sur l\u2019immunisation du Quebec . [Opinion on the appropriateness of adding the vaccination against shingles to the Quebec Immunization Program. Author: Committee on Immunization of Quebec (CIQ)]. [Article in French] [Internet. Accessed October 21, 2019.] Available from: catalogue.santecom.qc.ca\/cgi-bin\/koha\/opac-detail.plbiblionumber=110411"},{"key":"2020050109252807000_47.5.770.11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1874312901610010039","article-title":"Hepatitis B serology in patients with rheumatic diseases","volume":"10","author":"Feuchtenberger","year":"2016","journal-title":"Open Rheumatol J"},{"key":"2020050109252807000_47.5.770.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120165"},{"key":"2020050109252807000_47.5.770.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2020050109252807000_47.5.770.14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.vaccine.2015.01.065","article-title":"Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort","volume":"33","author":"Hmamouchi","year":"2015","journal-title":"Vaccine"},{"key":"2020050109252807000_47.5.770.15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/03009742.2016.1242774","article-title":"Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)","volume":"46","author":"Nguyen","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"2020050109252807000_47.5.770.16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jbspin.2015.02.016","article-title":"Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs","volume":"83","author":"Michel","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2020050109252807000_47.5.770.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep440"},{"key":"2020050109252807000_47.5.770.18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semarthrit.2013.04.003","article-title":"Primary preventive services in patients with systemic lupus erythematosus: study from a population-based sample in Southeast U.S","volume":"43","author":"Drenkard","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"2020050109252807000_47.5.770.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.01.002"},{"key":"2020050109252807000_47.5.770.20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.060285"},{"key":"2020050109252807000_47.5.770.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.10.012"},{"key":"2020050109252807000_47.5.770.22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq297"},{"key":"2020050109252807000_47.5.770.23","doi-asserted-by":"crossref","first-page":"e0153848","DOI":"10.1371\/journal.pone.0153848","article-title":"Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: a retrospective cohort study using data from the Clinical Practice Research Datalink","volume":"11","author":"Costello","year":"2016","journal-title":"PLoS One"},{"key":"2020050109252807000_47.5.770.24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jbspin.2015.11.005","article-title":"Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: a retrospective study","volume":"83","author":"Brocq","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2020050109252807000_47.5.770.25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jbspin.2016.03.013","article-title":"Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and\/or immunosuppressive therapies for systemic autoimmune diseases: a cross-sectional study","volume":"84","author":"Assala","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2020050109252807000_47.5.770.26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jbspin.2015.08.008","article-title":"Vaccinations in adults with chronic inflammatory joint disease: immunization schedule and recommendations for patients taking synthetic or biological disease-modifying antirheumatic drugs","volume":"83","author":"Morel","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2020050109252807000_47.5.770.27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00296-016-3608-y","article-title":"Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic","volume":"37","author":"Krasselt","year":"2017","journal-title":"Rheumatol Int"},{"key":"2020050109252807000_47.5.770.28","unstructured":"Dub\u00e9 \u00c9 Kiely M Ouakki M . [Quebec survey on vaccination against seasonal flu and pneumococcus and the determinants of vaccination: 2016: investigation report.] [Article in French] [Internet. Accessed October 21, 2019.] Available from: catalogue.santecom.qc.ca\/cgi-bin\/koha\/opac-detail.pl?biblionumber=96535"},{"key":"2020050109252807000_47.5.770.29","doi-asserted-by":"publisher","DOI":"10.1186\/ar3497"},{"key":"2020050109252807000_47.5.770.30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160179"},{"key":"2020050109252807000_47.5.770.31","unstructured":"Government of Canada . Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2017\u20132018. [Internet. Accessed October 21, 2019.] Available from: www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-statement-seasonal-influenza-vaccine-2017-2018.html"},{"key":"2020050109252807000_47.5.770.32","unstructured":"Government of Canada . Page 16: Canadian immunization guide: part 4 - active vaccines. [Internet. Accessed October 21, 2019.] Available from: www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-16-pneumococcal-vaccine.html"},{"key":"2020050109252807000_47.5.770.33","unstructured":"Government of Canada . Vaccination coverage goals and vaccine preventable disease reduction targets by 2025. [Internet. Accessed October 21, 2019.] Available from: www.canada.ca\/en\/public-health\/services\/immunization-vaccine-priorities\/national-immunization-strategy\/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html"},{"key":"2020050109252807000_47.5.770.34","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1016\/j.vaccine.2015.06.012","article-title":"Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency","volume":"33","author":"Loubet","year":"2015","journal-title":"Vaccine"},{"key":"2020050109252807000_47.5.770.35","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180300"},{"key":"2020050109252807000_47.5.770.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2005.10.016"},{"key":"2020050109252807000_47.5.770.37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2002.11040.x"},{"key":"2020050109252807000_47.5.770.38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/1062860612456236","article-title":"Delivering influenza vaccine to high-risk adults: subspecialty physician practices","volume":"28","author":"Jessop","year":"2012","journal-title":"Am J Med Qual"},{"key":"2020050109252807000_47.5.770.39","unstructured":"Public Health Agency of C . Epi-update: brief report: Hepatitis B infection in Canada. [Internet. Accessed October 21, 2019.] Available from: www.phac-aspc.gc.ca\/id-mi\/pdf\/hepB-eng.pdf"},{"key":"2020050109252807000_47.5.770.40","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s10067-019-04430-7","article-title":"Interventions to improve vaccine acceptance among rheumatoid arthritis patients: a systematic review","volume":"38","author":"Gosselin Boucher","year":"2019","journal-title":"Clinical Rheumatol"},{"key":"2020050109252807000_47.5.770.41","doi-asserted-by":"publisher","DOI":"10.1002\/art.24873"},{"key":"2020050109252807000_47.5.770.42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/pch\/19.6.310","article-title":"Canadian paediatricians\u2019 approaches to managing patients with adverse events following immunization: the role of the Special Immunization Clinic network","volume":"19","author":"Top","year":"2014","journal-title":"Paediatr Child Health"},{"key":"2020050109252807000_47.5.770.43","first-page":"CD005188","article-title":"Interventions to increase influenza vaccination rates of those 60 years and older in the community","volume":"5","author":"Thomas","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050109252807000_47.5.770.44","doi-asserted-by":"publisher","DOI":"10.1002\/art.37716"},{"key":"2020050109252807000_47.5.770.45","first-page":"15","article-title":"Use of standing orders programs to increase adult vaccination rates: recommendations of the Advisory Committee on Immunization Practices","volume":"49","author":"McKibben","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"2020050109252807000_47.5.770.46","first-page":"331","article-title":"Using medical record reminders to improve pneumococcal vaccination rates","volume":"30","author":"Warner","year":"2004","journal-title":"Joint Jt Comm J Qual Saf"},{"key":"2020050109252807000_47.5.770.47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7156.465"},{"key":"2020050109252807000_47.5.770.48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12891-016-1187-4","article-title":"A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK","volume":"17","author":"Subesinghe","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"2020050109252807000_47.5.770.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.050"},{"key":"2020050109252807000_47.5.770.50","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.10.850"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.181376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T16:26:53Z","timestamp":1588350413000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.181376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,5,1]]}},"alternative-id":["10.3899\/jrheum.181376"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.181376","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}